N M Bass

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Primary sclerosing cholangitis
    Harry J Rodriguez
    Division of Gastroenterology, UCSF School of Medicine, Box 0538, Room 357 S, San Francsico, CA 94143 0538, USA
    Semin Gastrointest Dis 14:189-98. 2003
  2. ncbi request reprint Down-regulation of liver and heart specific fatty acid binding proteins by endotoxin and cytokines in vivo
    R A Memon
    Department of Medicine, University of California, San Francisco, CA 94143, USA
    Biochim Biophys Acta 1440:118-26. 1999
  3. ncbi request reprint A randomized trial of exercise and dietary counseling after liver transplantation
    J B Krasnoff
    Department of Physiological Nursing, University of California, San Francisco, USA
    Am J Transplant 6:1896-905. 2006
  4. ncbi request reprint Review article: the current pharmacological therapies for hepatic encephalopathy
    N M Bass
    UCSF Liver Transplantation Service, School of Medicine, University of California, San Francisco, CA 94143 0538, USA
    Aliment Pharmacol Ther 25:23-31. 2007
  5. ncbi request reprint Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging
    F Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Am J Transplant 7:2587-96. 2007
  6. ncbi request reprint Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival
    F Y Yao
    Department of Medicine, University of California, San Francisco 94143 0538, USA
    Hepatology 33:1394-403. 2001
  7. ncbi request reprint Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort
    F Y Yao
    Department of Medicine, Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Hepatology 34:411-6. 2001
  8. ncbi request reprint Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
    F Y Yao
    Department of Transplantation, California Pacific Medical Center, San Francisco 94143 0538, USA
    J Hepatol 33:301-7. 2000
  9. ncbi request reprint Intestinal fatty acid binding protein may favor differential apical fatty acid binding in the intestine
    D H Alpers
    Division of Gastroenterology, Washington University School of Medicine, St Louis, MO 63110 1010, USA
    Biochim Biophys Acta 1483:352-62. 2000
  10. ncbi request reprint Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry
    Kris V Kowdley
    University of Washington, Seattle, 98195, USA
    Gastroenterology 129:494-503. 2005

Collaborators

Detail Information

Publications42

  1. ncbi request reprint Primary sclerosing cholangitis
    Harry J Rodriguez
    Division of Gastroenterology, UCSF School of Medicine, Box 0538, Room 357 S, San Francsico, CA 94143 0538, USA
    Semin Gastrointest Dis 14:189-98. 2003
    ..The diagnosis of cholangiocarcinoma--often difficult and elusive--usually precludes liver transplantation because its prognosis is very poor...
  2. ncbi request reprint Down-regulation of liver and heart specific fatty acid binding proteins by endotoxin and cytokines in vivo
    R A Memon
    Department of Medicine, University of California, San Francisco, CA 94143, USA
    Biochim Biophys Acta 1440:118-26. 1999
    ..The LPS-induced decrease in L-FABP and H-FABP may be an additional mechanism contributing to the decrease in FA oxidation that is associated with the host response to infection and inflammation...
  3. ncbi request reprint A randomized trial of exercise and dietary counseling after liver transplantation
    J B Krasnoff
    Department of Physiological Nursing, University of California, San Francisco, USA
    Am J Transplant 6:1896-905. 2006
    ..These data suggest improvements in exercise capacity and body composition are achieved with nutrition and exercise behavior modifications initiated early after OLT and with regular follow-up...
  4. ncbi request reprint Review article: the current pharmacological therapies for hepatic encephalopathy
    N M Bass
    UCSF Liver Transplantation Service, School of Medicine, University of California, San Francisco, CA 94143 0538, USA
    Aliment Pharmacol Ther 25:23-31. 2007
    ..In conclusion, non-absorbed antibiotics such as rifaximin offer a favourable benefit-risk ratio in the treatment of hepatic encephalopathy and may help to improve patient outcomes...
  5. ncbi request reprint Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging
    F Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Am J Transplant 7:2587-96. 2007
    ....
  6. ncbi request reprint Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival
    F Y Yao
    Department of Medicine, University of California, San Francisco 94143 0538, USA
    Hepatology 33:1394-403. 2001
    ..0005). We conclude that the current criteria for OLT based on tumor size may be modestly expanded while still preserving excellent survival after OLT...
  7. ncbi request reprint Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort
    F Y Yao
    Department of Medicine, Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Hepatology 34:411-6. 2001
    ..However, the small sample size and the use of a retrospective control cohort preclude drawing definitive conclusions. Expedited OLT remains the only viable treatment for lamivudine nonresponders...
  8. ncbi request reprint Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
    F Y Yao
    Department of Transplantation, California Pacific Medical Center, San Francisco 94143 0538, USA
    J Hepatol 33:301-7. 2000
    ..The aim of this study was to evaluate the effectiveness of lamivudine treatment in severely decompensated cirrhosis due to chronic hepatitis B...
  9. ncbi request reprint Intestinal fatty acid binding protein may favor differential apical fatty acid binding in the intestine
    D H Alpers
    Division of Gastroenterology, Washington University School of Medicine, St Louis, MO 63110 1010, USA
    Biochim Biophys Acta 1483:352-62. 2000
    ..These data are consistent with the hypothesis that I-FABP may contribute to the metabolic compartmentalization of apically presented fatty acids in the intestine...
  10. ncbi request reprint Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry
    Kris V Kowdley
    University of Washington, Seattle, 98195, USA
    Gastroenterology 129:494-503. 2005
    ..We examined the effect of HFE mutations on posttransplantation survival in patients with hepatic iron overload...
  11. ncbi request reprint A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
    Francis Y Yao
    Department of Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0538, USA
    Liver Transpl 11:1505-14. 2005
    ..3 and 81.8% at 1 and 2 yr, respectively. In conclusion, successful tumor downstaging can be achieved in the majority of carefully selected patients, but longer follow-up is needed to further access the risk of HCC recurrence after OLT...
  12. ncbi request reprint Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
    Raphael B Merriman
    Division of Gastroenterology, Department of Medicine, University of California San Francisco, CA 94143 0538, USA
    Hepatology 44:874-80. 2006
    ..In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease...
  13. ncbi request reprint Abnormal liver function tests in the patient transplanted 3 years ago for alcoholic liver disease
    Nathan M Bass
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143 0538, USA
    Liver Transpl 12:S76-82. 2006
  14. pmc Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers
    Manisha Bahl
    Department of Radiology, University of California, San Francisco, Box 0628, L 307, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Radiology 249:160-6. 2008
    ....
  15. ncbi request reprint Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol
    Oren K Fix
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Liver Transpl 13:875-85. 2007
    ..Liver biochemistries are not greatly changed. Survival seemed not to differ between treatment groups. A minority of patients treated with epoprostenol will improve sufficiently to undergo OLT...
  16. pmc Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease
    Joanne B Krasnoff
    Exercise Physiology and Body Composition Laboratory, CTSI Clinical Research Center, University of California San Francisco, San Francisco, CA 94143 0126, USA
    Hepatology 47:1158-66. 2008
    ..2%) among the steatosis or fibrosis groups. Peak VO(2) was significantly higher in NAS1 versus NAS2 (30.4 +/- 8.2 versus 24.4 +/- 5.7 mL/kg/min, P = 0.013) and NotNASH versus NASH (34.0 +/- 9.5 versus 25.1 +/- 5.7 mL/kg/min, P = 0.048)...
  17. pmc Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease
    Naga Chalasani
    Indiana University School of Medicine, 1050 Wishard Boulevard, Indianapolis, IN 46202, USA
    J Hepatol 48:829-34. 2008
    ..The relationship between severity and zonal location of steatosis and the presence of steatohepatitis and various histological features that define NASH has not been formally studied...
  18. doi request reprint A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
    Guilherme M Campos
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143 0790, USA
    Hepatology 47:1916-23. 2008
    ..3; 95% CI, 1.4-8.0), and non-Black race (OR, 8.4; 95% CI, 1.9-37.1). A NASH Clinical Scoring System for Morbid Obesity was derived to predict the probability of NASH in four categories (low, intermediate, high, and very high)...
  19. pmc Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis
    Francis Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Hepatology 48:819-27. 2008
    ..2% and 92.1%, respectively. No patient had HCC recurrence after a median posttransplantation follow-up of 25 months. The only factor predicting treatment failure was pretreatment alpha-fetoprotein >1,000 ng/mL...
  20. ncbi request reprint The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma
    Francis Y Yao
    Department of Medicine, University of California, San Francisco, CA, USA
    Am J Transplant 5:795-804. 2005
    ....
  21. ncbi request reprint A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy
    Francis Y Yao
    Department of Medicine, Division of Gastroenterology, University of California, San Francisco 94143, USA
    Liver Transpl 9:684-92. 2003
    ..004). In conclusion, the low dropout rate in the first 6 months and the differing dropout risks based on tumor characteristics support further refinements in the HCC-adjusted MELD organ allocation scheme...
  22. ncbi request reprint Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores
    Francis Y Yao
    Department of Medicine University of California, San Francisco, San Francisco, CA, USA
    Hepatology 39:230-8. 2004
    ..In conclusion, our results suggest that severity of graft failure based on CTP and MELD scores may be associated with worse outcome after re-OLT and provide a cautionary note for the "sickest first" policy of organ allocation...
  23. ncbi request reprint Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list
    Francis Y Yao
    Department of Medicine, Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Liver Transpl 8:873-83. 2002
    ..Our results support recent changes in the scheme of organ allocation aimed at reducing the dropout rate and improving outcome for patients with HCC awaiting OLT...
  24. ncbi request reprint Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy
    Francis Y Yao
    Department of Medicine, Division of Gastroenterology, University of California, San Francisco, 94143 0538, USA
    Liver Transpl 10:621-30. 2004
    ..Compared with preliminary UNOS data, in which 90% of patients with HCC have received OLT within 3 months, our results reflect the wide regional variation in the impact of MELD...
  25. ncbi request reprint Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria
    Francis Y Yao
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143 0538, USA
    Liver Transpl 8:765-74. 2002
    ..UCSF criteria confer a different advantage over Pittsburgh criteria, which require information on microvascular invasion that is difficult to ascertain preoperatively without the attendant risk of biopsy...
  26. ncbi request reprint Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis
    Derek Patel
    Division of Gastroenterology, Department of Medicine, University of California, 513 Parnassus Avenue, San Francisco, CA 94143 0538, USA
    Clin Gastroenterol Hepatol 3:75-84. 2005
    ..Surveillance might detect HCC at a treatable stage. We estimated the clinical and economic consequences of a common HCC surveillance strategy in patients with HCV-related cirrhosis in the context of alternative HCC treatment strategies...
  27. ncbi request reprint Objective measures of health-related quality of life over 24 months post-liver transplantation
    Joanne B Krasnoff
    Department of Physiological Nursing, University of California San Francisco, San Francisco, CA 941430 0610, USA
    Clin Transplant 19:1-9. 2005
    ..A randomized clinical trial of lifestyle modifications such as diet and exercise intervention is warranted to determine the impact of such modifications on HRQoL and fitness post-OLT...
  28. ncbi request reprint Serum sodium predicts mortality in patients listed for liver transplantation
    Scott W Biggins
    Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
    Hepatology 41:32-9. 2005
    ..Addition of serum sodium to MELD increases the ability to predict 3- and 6-month mortality in patients with cirrhosis...
  29. ncbi request reprint Leukotriene antagonists
    Timothy J Davern
    University of California, Division of Gastroenterology, 513 Parnassus Avenue, Room S 357, San Francisco 94143, CA, USA
    Clin Liver Dis 7:501-12, viii. 2003
    ..It is in context of this heightened awareness of hepatotoxicity, particularly associated with new high profile drugs, that the authors reviews the published data regarding liver injury related to a novel group of asthma drugs...
  30. pmc Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels
    Brent A Neuschwander-Tetri
    Arch Intern Med 168:663-6. 2008
  31. ncbi request reprint Interactions of fluorochemicals with rat liver fatty acid-binding protein
    Deanna J Luebker
    3M Medical Department, Corporate Toxicology, 3M Center Building 220 2E 02, Saint Paul, MN 55144, USA
    Toxicology 176:175-85. 2002
    ..Furthermore, this work provides evidence to support the hypothesis that displacement of endogenous ligands from L-FABP may contribute to toxicity in rodents fed these fluorochemicals...
  32. ncbi request reprint It could have been something they ate -- functional food and the treatment of liver cancer
    Nathan M Bass
    J Hepatol 37:147-50. 2002
  33. ncbi request reprint Curricular guidelines for training in transplant hepatology
    Hugo R Rosen
    Liver and Intra Abdominal Subcommittee, American Society for Transplantation, USA
    Liver Transpl 8:85-7. 2002
  34. ncbi request reprint Medical treatment of non-alcoholic steatohepatitis
    Abdurrahman Kadayifci
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143 0538, USA
    Clin Liver Dis 11:119-40, ix. 2007
    ..The future will see the evaluation of novel agents and a comprehensive treatment strategy that addresses the risk factors for the metabolic syndrome. This article reviews the current status of medical management options for NASH...
  35. ncbi request reprint Amyloidosis localized to the liver
    Oren K Fix
    Division of Gastroenterology, University of California, San Francisco, San Francisco, California, USA
    Clin Gastroenterol Hepatol 5:e7. 2007
  36. ncbi request reprint CT signs of hepatofugal portal venous flow in patients with cirrhosis
    Thomas J Bryce
    Department of Medicine and Department of Radiology, Abdominal Imaging Section, University of California at San Francisco, San Francisco, CA 94143 0628, USA
    AJR Am J Roentgenol 181:1629-33. 2003
    ..We investigated whether CT signs can be used to predict hepatofugal flow in the main portal vein in patients with cirrhosis...
  37. ncbi request reprint Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation
    Amin A Nanji
    Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104 4283, USA
    J Pharmacol Exp Ther 310:417-24. 2004
    ....
  38. ncbi request reprint Genetic influences in nonalcoholic fatty liver disease
    Raphael B Merriman
    Division of Gastroenterology, University of California, San Francisco, San Francisco, CA 94143, USA
    J Clin Gastroenterol 40:S30-3. 2006
    ..Identification of the genetic contribution to NAFLD will inform theories of disease pathogenesis and progression and ultimately improve management...
  39. ncbi request reprint Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease
    Paul D Mintz
    Department of Pathology, University of Virginia, Charlottesville, 22908 0286, USA
    Blood 107:3753-60. 2006
    ..No differences were observed in use of blood components, clinical hemostasis, or safety. These results suggest PCT-FFP supported hemostasis in the treatment of acquired coagulopathy similarly to conventional FFP...
  40. ncbi request reprint Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis
    Burton Combes
    The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Hepatology 42:1184-93. 2005
    ..In conclusion, methotrexate when added to UDCA for a median period of 7.6 years had no effect on the course of PBC treated with UDCA alone...
  41. ncbi request reprint High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome
    Elizabeth Cruz
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, CA 94143 0538, USA
    Clin Transplant 19:501-6. 2005
    ..We evaluated the long-term outcome, risks for recurrent disease, and other hematologic complications following orthotopic liver transplantation (OLT) for BCS...
  42. ncbi request reprint Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease
    Shiobhan R Weston
    Department of Medicine, University of California at San Francisco, USA
    Hepatology 41:372-9. 2005
    ..Clinicians need to be aware of the variable presentations of NAFLD in different racial and ethnic groups...